Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)

Part of paid clinical trials in Oklahoma City, Oklahoma.

Sponsor
University of Oklahoma
Study ID
NCT06960798
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
MALE
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • Bio-specimen Collection — OTHER
    Tissue samples will be taken from existing archived collections and sent for further analysis.
  • Blood Draw — OTHER
    Blood samples will be collected within the first year of enrollment.

Study Details

The purpose of this study is to analyze tumor tissue samples from patients of Native American identity with prostate cancer. By examining these samples, researchers hope to understand how different genes in your tumor can influence treatment decisions, how your cancer progresses and the outcome of your cancer.

Key Dates

Start date
May 2, 2026
Status verified
Feb 2026
Primary completion
May 30, 2028
Completion
Jun 30, 2029

Study Design

Enrollment
150 participants (estimated)

Arms

  • Arm: Native American Group
    150 patients will be assigned in this group.

Primary Outcome Measure

Difference in the genomic profiles of Prostate Cancer [ Time Frame: 1-3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
OU Health Stephenson Cancer CenterOklahoma CityOklahoma73117
Adanma Ayanambakkam, MD
[email protected]
405-271-4022

Find similar trials in Oklahoma City, OK

By condition
Prostate cancer
By specialty
OncologyProstate oncologyMen's healthUrology
By research site
OU Health Stephenson Cancer Center· Oklahoma City, OK

Related Studies